• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病危险因素的病例对照研究:病例与对照的抽样如何影响结果?

Case-control studies on risk factors for chronic obstructive pulmonary disease: how does the sampling of the cases and controls affect the results?

作者信息

Sørheim Inga-Cecilie, Johannessen Ane, Grydeland Thomas Blix, Omenaas Ernst Reidar, Gulsvik Amund, Bakke Per Sigvald

机构信息

Institute of Medicine, University of Bergen, Bergen, Norway.

出版信息

Clin Respir J. 2010 Apr;4(2):89-96. doi: 10.1111/j.1752-699X.2009.00154.x.

DOI:10.1111/j.1752-699X.2009.00154.x
PMID:20565482
Abstract

INTRODUCTION

Sampling is regarded as crucial to the validity of case-control studies. Ideally, cases and controls should be selected from the same source population, but deviations from this approach are often seen.

OBJECTIVE

Our objective was to examine how exposure-disease relationships in a study on chronic obstructive pulmonary disease (COPD) were affected by the sampling sources of cases and controls.

METHODS

A Norwegian case-control study on COPD including 1909 subjects used three sources of recruitment for cases (general population, hospital registry and volunteers) and two sources for controls (general population and volunteers). This resulted in six sampling combinations of cases and controls (groups A-F). We examined how the risk factors gender, age, smoking, educational level and comorbidity were associated with COPD in these six sampling groups.

RESULTS

Several exposure-disease associations were dependent on variation in sampling source, thereby demonstrating the possibility of selection bias. The theoretically most ideal sampling group is likely group A, where both cases and controls are recruited from a general population. When using group A as a reference, the groups containing either voluntary controls and/or hospital-based cases deviated the most, suggesting higher susceptibility to selection bias in these groups.

CONCLUSION

Recruitment from several sources made our study design vulnerable to selection bias. Our findings should bring about increased awareness to the sampling process, and encourage sampling of cases and controls from the same source population in future studies.

摘要

引言

抽样被认为对病例对照研究的有效性至关重要。理想情况下,病例和对照应从同一源人群中选取,但这种方法的偏差屡见不鲜。

目的

我们的目的是研究慢性阻塞性肺疾病(COPD)研究中病例和对照的抽样来源如何影响暴露与疾病的关系。

方法

一项挪威的COPD病例对照研究纳入了1909名受试者,病例的招募来源有三个(普通人群、医院登记和志愿者),对照的来源有两个(普通人群和志愿者)。这产生了病例和对照的六种抽样组合(A - F组)。我们研究了这六个抽样组中性别、年龄、吸烟、教育水平和合并症等危险因素与COPD的关联。

结果

一些暴露与疾病的关联取决于抽样来源的差异,从而证明了选择偏倚的可能性。理论上最理想的抽样组可能是A组,即病例和对照均从普通人群中招募。以A组作为参照时,包含志愿对照和/或医院病例的组偏差最大,表明这些组更容易受到选择偏倚的影响。

结论

从多个来源招募受试者使我们的研究设计容易受到选择偏倚的影响。我们的研究结果应提高对抽样过程的认识,并鼓励在未来的研究中从同一源人群中抽取病例和对照。

相似文献

1
Case-control studies on risk factors for chronic obstructive pulmonary disease: how does the sampling of the cases and controls affect the results?慢性阻塞性肺疾病危险因素的病例对照研究:病例与对照的抽样如何影响结果?
Clin Respir J. 2010 Apr;4(2):89-96. doi: 10.1111/j.1752-699X.2009.00154.x.
2
Genetics of chronic obstructive pulmonary disease: a case-control study in Bergen, Norway.慢性阻塞性肺疾病的遗传学:挪威卑尔根的一项病例对照研究。
Clin Respir J. 2008 Oct;2 Suppl 1:129-31. doi: 10.1111/j.1752-699X.2008.00097.x.
3
Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population.普通成年人群中慢性阻塞性肺疾病的全球慢性阻塞性肺疾病倡议(GOLD)定义发病率。
Int J Tuberc Lung Dis. 2005 Aug;9(8):926-32.
4
[Occupational chronic obstructive pulmonary disease: Italian law (decree no. 336/1994) and epidemiological evidence].[职业性慢性阻塞性肺疾病:意大利法律(第336/1994号法令)及流行病学证据]
Med Lav. 2004 Jan-Feb;95(1):11-6.
5
Better understanding the influence of cigarette smoking and indoor air pollution on chronic obstructive pulmonary disease: a case-control study in Mainland China.深入了解吸烟和室内空气污染对慢性阻塞性肺疾病的影响:中国大陆的一项病例对照研究。
Respirology. 2007 Nov;12(6):891-7. doi: 10.1111/j.1440-1843.2007.01178.x.
6
Norwegian population surveys on respiratory health in adults: objectives, design, methods, quality controls and response rates.挪威成年人呼吸健康状况的人口调查:目标、设计、方法、质量控制及应答率。
Clin Respir J. 2008 Oct;2 Suppl 1:10-25. doi: 10.1111/j.1752-699X.2008.00080.x.
7
Genetic and biochemical markers of obstructive lung disease in the general population.普通人群中阻塞性肺疾病的遗传和生化标志物。
Clin Respir J. 2009 Apr;3(2):121-2. doi: 10.1111/j.1752-699X.2008.00110.x.
8
The Obstructive Lung Disease in Northern Sweden Chronic Obstructive Pulmonary Disease Study: design, the first year participation and mortality.瑞典北部阻塞性肺病慢性阻塞性肺疾病研究:设计、第一年参与情况及死亡率
Clin Respir J. 2008 Oct;2 Suppl 1:64-71. doi: 10.1111/j.1752-699X.2008.00086.x.
9
Psoriasis and chronic obstructive pulmonary disease: a case-control study.银屑病与慢性阻塞性肺疾病:一项病例对照研究。
Br J Dermatol. 2008 Sep;159(4):956-60. doi: 10.1111/j.1365-2133.2008.08749.x. Epub 2008 Jul 15.
10
Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey.中国慢性阻塞性肺疾病的患病率:一项基于人群的大型调查。
Am J Respir Crit Care Med. 2007 Oct 15;176(8):753-60. doi: 10.1164/rccm.200612-1749OC. Epub 2007 Jun 15.

引用本文的文献

1
Gut microbiota in chronic obstructive pulmonary disease varies by CT-verified emphysema status.慢性阻塞性肺疾病中的肠道微生物群因CT证实的肺气肿状态而异。
Eur Clin Respir J. 2025 Feb 26;12(1):2470499. doi: 10.1080/20018525.2025.2470499. eCollection 2025.
2
Polygenic risk scores identify heterogeneity in asthma and chronic obstructive pulmonary disease.多基因风险评分可识别哮喘和慢性阻塞性肺疾病的异质性。
J Allergy Clin Immunol. 2023 Dec;152(6):1423-1432. doi: 10.1016/j.jaci.2023.08.002. Epub 2023 Aug 16.
3
The airway microbiota and exacerbations of COPD.
气道微生物群与慢性阻塞性肺疾病的急性加重
ERJ Open Res. 2020 Aug 31;6(3). doi: 10.1183/23120541.00168-2020. eCollection 2020 Jul.
4
Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohorts.慢性阻塞性肺疾病及相关表型:基于人群和病例对照队列的多基因风险评分。
Lancet Respir Med. 2020 Jul;8(7):696-708. doi: 10.1016/S2213-2600(20)30101-6.
5
Complications and discomfort after research bronchoscopy in the MicroCOPD study.研究性支气管镜检查后在 MicroCOPD 研究中的并发症和不适。
BMJ Open Respir Res. 2020 Mar;7(1). doi: 10.1136/bmjresp-2019-000449.
6
Prevalence and prognostic ability of the GOLD 2017 classification compared to the GOLD 2011 classification in a Norwegian COPD cohort.在挪威 COPD 队列中,与 GOLD 2011 分类相比,GOLD 2017 分类的流行率和预后能力。
Int J Chron Obstruct Pulmon Dis. 2019 Jul 23;14:1639-1655. doi: 10.2147/COPD.S194019. eCollection 2019.
7
Motivation and response rates in bronchoscopy studies.支气管镜检查研究中的动机和反应率。
Multidiscip Respir Med. 2019 May 2;14:14. doi: 10.1186/s40248-019-0178-3. eCollection 2019.
8
Genetic Association and Risk Scores in a Chronic Obstructive Pulmonary Disease Meta-analysis of 16,707 Subjects.16707名受试者的慢性阻塞性肺疾病荟萃分析中的基因关联与风险评分
Am J Respir Cell Mol Biol. 2017 Jul;57(1):35-46. doi: 10.1165/rcmb.2016-0331OC.
9
The Bergen COPD microbiome study (MicroCOPD): rationale, design, and initial experiences.卑尔根慢性阻塞性肺疾病微生物组研究(MicroCOPD):原理、设计与初步经验
Eur Clin Respir J. 2014 Dec 29;1. doi: 10.3402/ecrj.v1.26196. eCollection 2014.
10
Productivity losses in chronic obstructive pulmonary disease: a population-based survey.慢性阻塞性肺疾病的生产力损失:一项基于人群的调查。
BMJ Open Respir Res. 2014 Dec 1;1(1):e000049. doi: 10.1136/bmjresp-2014-000049. eCollection 2014.